Here is a study which questions the safety of uridine use as the results suggest that it may be carcinogenic.
Uridine homeostatic disorder leads to DNA damage and tumorigenesis
Highlights
• Uridine homeostatic disorder induced by uridine phosphorylase knockout leads to DNA damage and spontaneous tumorigenesis.
• Addition of uridine into culture medium causes uracil DNA damage and p53-mediated DNA damage response (DDR).
• Pharmacological use of uridine may be carcinogenic, and the far-reaching effects need to be considered.
Abstract
Uridine is a natural nucleoside precursor of uridine monophosphate in organisms and thus is considered to be safe and is used in a wide range of clinical settings. The far-reaching effects of pharmacological uridine have long been neglected. Here, we report that the homeostatic disorder of uridine is carcinogenic. Targeted disruption (−/−) of murine uridine phosphorylase (UPase) disrupted the homeostasis of uridine and increased spontaneous tumorigenesis by more than 3-fold. Multiple tumors (e.g., lymphoma, hepatoma and lung adenoma) occurred simultaneously in some UPase deficient mice, but not in wild-type mice raised under the same conditions. In the tissue from UPase −/− mice, the 2′-deoxyuridine,5′-triphosphate (dUTP) levels and uracil DNA were increased and p53 was activated with an increased phospho-Ser18 p53 level. Exposing cell lines (e.g., MCF-7, RKO, HCT-8 and NCI-H460) to uridine (10 or 30 µM) led to uracil DNA damage and p53 activation, which in turn triggered the DNA damage response. In these cells, phospho-ATM, phospho-CHK2, and phospho-γH2AX were increased by uridine. These data suggest that uridine homeostatic disorder leads to uracil DNA damage and that pharmacological uridine may be carcinogenic.
http://www.sciencedi...304383516000197
From the final paragraph:
...uridine is even used in healthy subjects for neurological studies. To achieve treatment efficacy, pharmacological concentrations of uridine in the plasma are usually higher than 50 μM, even up to 2–3 mM. This study demonstrated that uridine at 30 μM is genotoxic. Therefore, the pharmacological doses of uridine in clinical settings may be genotoxic and carcinogenic. The far-reaching detrimental effects (e.g., carcinogenesis) of the pharmacological use of uridine have to be considered, and the safety of uridine treatment, particularly in healthy subjects, has to be re-evaluated.
Notably this study used UPase knockout mice and no actual uridine was administered. Either way this is cause for concern. I know that Chrono had some reservations with regard to carcinogenicity, maybe these weren't so misfounded.
This is a pain for me as I have already ordered some tricetyluridine to try, maybe it is wise to hold off with this until there is some follow-up research.
Edited by Ryu84, 21 June 2016 - 02:43 PM.